Pharmacopeia (PCOP) Reduces Workforce by 28%
In a Form 8-K, Pharmacopeia (Nasdaq: PCOP) announced that on December 19, 2008, it reduced its workforce by approximately 28% through termination of positions. The Company notified the 22 affected employees of their termination dates, all of which will be as of January 2, 2009. Substantially all of the severance cost is expected to result in future cash expenditures.
Pharmacopeia, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to address significant medical needs.
Pharmacopeia, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to address significant medical needs.
You May Also Be Interested In
- Syngenta (SYT) settles atrazine litigation; will pay $105M in deal
- New York Mortgage Trust (NYMT) Prices 2.75M Offering at $6.65/Share
- Baxter Int'l (BAX) says low-glucose PD regimen has favorable impact on ESRD patients w/ diabetes
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
LayoffsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
